Vascular occlusion remains the leading cause of death in Western countries, despite
advances made in balloon angioplasty and conventional surgical intervention. Vascular …

Despite all the progress achieved since Scribner first introduced the arteriovenous (AV)
shunt in 1960 and Cimino and Brescia introduced the native AV fistula in 1962, we have …

An arteriovenous fistula is the current gold standard for chronic hemodialysis access.
Tunneled catheters or synthetic grafts have poorer outcomes and much higher risks of …

Haemodialysis vascular access patency is severely compromised by fistula non-maturation
and access stenosis. Intimal hyperplasia (IH) is considered the culprit lesion in failed fistulas …

Cardiovascular diseases (CVDs) are life-threatening diseases with high morbidity and
mortality worldwide. Vascular bypass surgery is still the ultimate strategy for CVD treatment …

Background: Cardiovascular bypass grafting is an essential treatment for complex cases of
atherosclerotic disease. Because the availability of autologous arterial and venous conduits …

Clinically available alternatives of vascular access for long-term haemodialysis—currently
limited to native arteriovenous fistulae and synthetic grafts—suffer from several drawbacks …

Importance Vascular injuries require urgent repair to minimize loss of limb and life. Standard
revascularization relies on autologous vein or synthetic grafts, but alternative options are …

Implant-associated infections are caused by microorganisms which adhere to the device
and form biofilms. Medical devices are highly susceptible to bacterial and fungal infections …

To solve the problem of vascular access failure, a novel semi‐degradable hybrid vascular
graft, manufactured by electrospinning using silk fibroin and polyurethane (Silkothane), has …